Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

VWK147

SKU: orb3210249

Description

VWK147 is a second-generation HSP90 C-terminal domain (CTD) inhibitor. It acts on the CTD dimerization interface, preventing the dimerization of HSP90CTD, disrupting the binding of the co-chaperone protein PPID with HSP90CTD, and inhibiting dimerization-dependent functions of HSP90. VWK147 reduces the protein levels of HSP90 client proteins ULK1, RIPK1, and CDK4 without inducing a heat shock response. It induces cell death, including apoptosis (apoptosis), in both cisplatin-sensitive and resistant urothelial carcinoma cells. VWK147 causes LC3-II accumulation, inhibits autophagosome-lysosome fusion to block classical autophagy (autophagy), and triggers non-classical LC3 lipidation independent of the ULK1 and PIK3C3 complex. VWK147 is applicable to research on urothelial carcinoma.

Images & Validation

Key Properties

TargetCDK,Autophagy,RIP kinase,Apoptosis,HSP

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information